The Intelligence: Split bill

The Intelligence: Split bill

Up next

Forever young: the business of longevity drugs

The success of GLP-1s has prompted biotechs to approach the challenge differently. After years of false starts and disappointing results, longevity drugs could be on the horizon. Do immigrants from some countries commit more sex crimes? And the big business of miniatures. Guests ...  Show more

Not in Kansas any more: Republicans get a thrashing

In the end, the result was clear and uncontested: Democrats had an astonishingly good night. Our editors and correspondents across America report on the proceedings, and we ask what comes next—for Democrats, for Republicans and for Trumpism more widely.Guests and host:Edward Carr ...  Show more

Recommended Episodes

The Intelligence: Split bill
The Intelligence from The Economist

After an all-nighter, a $95bn foreign aid bill for Ukraine and other allies passed the US Senate. But amid much division, it may not even make it to a House vote. <a href="https://www.economist.com/asia/2024/01/28/the-hindu-rights-pro-cow-policies-are-terrible-for-indias-cows? ...

  Show more

The Intelligence: Zelensky’s plea
The Intelligence from The Economist

Volodymyr Zelensky is hoping to secure <a href="https://www.economist.com/europe/2023/12/11/volodymyr-zelensky-tries-to-shake-congress-out-of-paralysis?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes ...

  Show more

The Intelligence: Is time up for TikTok?
The Intelligence from The Economist

The US Congress is refusing to scroll past the app’s links to China. If the bill they passed becomes law, <a href="https://www.economist.com/leaders/2024/03/12/time-for-tiktok-to-cut-its-ties-to-china?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm ...

  Show more